€12m
▲ Purchases (20 ops.)
Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Bailey Gregory. Insider active across 3 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 23 filings have been logged. Breakdown: 20 buys · 0 sell. Total volume traded: €11.9m. Activity tracked since 19 August 2022. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations 23 total
59,667 shares @ US$1.94 0.34% mcap 23.2% of flow Common Stock SEC:0001329505-26-000002:0
3,866 shares @ US$4.5899 3.9% of flow Common Stock SEC:0001493152-24-050774:0
Ideal exit: 13 Sept 2025 (T+270) 5,000 shares @ US$44.1932 3.3% of flow Common Shares SEC:0001935979-24-000075:0
Ideal exit: 21 Jun 2025 (T+270) 1,137 shares @ US$6.0259 1.4% of flow Common Stock SEC:0001493152-24-037965:0
Ideal exit: 17 Jun 2025 (T+270) 2,709 shares @ US$6.2285 3.5% of flow Common Stock SEC:0001493152-24-037714:0
Ideal exit: 15 Jun 2025 (T+270) 1,776 shares @ US$8.25 3.1% of flow Common Stock SEC:0001493152-24-033599:0
Ideal exit: 17 May 2025 (T+270) 6,400 shares @ US$6.6526 9.0% of flow Common Stock SEC:0001493152-24-033277:0
Ideal exit: 12 May 2025 (T+270) 6,400 shares @ US$7.3093 9.9% of flow Common Stock SEC:0001493152-24-033277:1
Ideal exit: 13 May 2025 (T+270) 6,400 shares @ US$7.9313 10.6% of flow Common Stock SEC:0001493152-24-033277:2
Ideal exit: 16 May 2025 (T+270) 6,400 shares @ US$7.0669 9.5% of flow Common Stock SEC:0001493152-24-032829:0
Ideal exit: 11 May 2025 (T+270) 1,173 shares @ US$9.50 2.4% of flow Common Stock SEC:0001493152-24-022200:0
Ideal exit: 23 Feb 2025 (T+270) 9,019 shares @ US$9.50 18.4% of flow Common Stock SEC:0001493152-24-021786:0
Ideal exit: 22 Feb 2025 (T+270) 916 shares @ US$9.50 1.9% of flow Common Stock SEC:0001493152-24-021358:0
Ideal exit: 15 Feb 2025 (T+270) 1,422 shares @ US$9.50 2.9% of flow Common Stock SEC:0001493152-24-021148:0
Ideal exit: 15 Feb 2025 (T+270) 100 shares @ US$9.00 0.2% of flow Common Stock SEC:0001493152-24-021013:0
Ideal exit: 14 Feb 2025 (T+270) 15,000 shares @ US$34.1918 8.0% of flow Common Shares SEC:0001562180-24-004045:0
Ideal exit: 7 Feb 2025 (T+270) 25,503 shares @ US$39.1785 15.6% of flow Common Shares SEC:0001562180-24-003521:0
Ideal exit: 19 Jan 2025 (T+270) 48,780 shares @ US$41.00 31.4% of flow Common Shares SEC:0001562180-24-003495:0
Ideal exit: 17 Jan 2025 (T+270) 17,817 shares @ US$22.568 6.4% of flow Common Shares SEC:0001562180-23-007228:0
Ideal exit: 30 Jun 2024 (T+270) 200,000 shares @ US$10.50 35.3% of flow Common Shares SEC:0001562180-22-007335:0
Ideal exit: 22 Jul 2023 (T+270) 1,291,829 shares 0Common Shares SEC:0001562180-22-007075:0
2,583,658 shares @ US$148.50 98.6% of flow Common Shares SEC:0001562180-22-006953:0
38,000 shares @ US$148.0441 1.4% of flow Common Stock SEC:0001562180-22-006259:0
Ideal exit: 16 May 2023 (T+270)